Old Web
English
Sign In
Acemap
>
Paper
>
Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders.
Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders.
2021
Yossi Rosman
Noa Lavi
Keren Meir-Shafrir
Idit Lachover-Roth
Anat Cohen Engler
Yoseph A. Mekori
Ronit Confino-Cohen
Keywords:
severe acute respiratory syndrome coronavirus 2
Messenger RNA
Mast cell
Immunology
Coronavirus disease 2019
Mast cell activation
2019 20 coronavirus outbreak
in patient
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
9
References
2
Citations
NaN
KQI
[]